Marketplace®

Daily business news and economic stories
Oct 9, 2019

Why Charles Schwab didn’t need to be the smartest guy in the room

Employees are quitting for greener pastures. Johnson & Johnson must pay a man $8 billion over the use of one of its drugs. Charles Schwab talks investments and dyslexia.

Why Charles Schwab didn’t need to be the smartest guy in the room
Justin Sullivan/Getty Images

Subscribe:

Segments From This Episode

Music from the episode

The Team

Why Charles Schwab didn’t need to be the smartest guy in the room